Maxcyte Income Statement (2020-2026) | MXCT

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
7.11M10.14M7.51M11.59M9.61M10.64M7.76M4.96M9.04M4.16M26.55M5.58M4.96M8.16M6.05M10.39M8.51M6.83M-4.77M4.50M
Gross Profit (Quarter)
6.32M9.20M8.93M10.52M8.49M9.27M10.88M7.58M7.67M7.21M14.09M9.94M8.94M6.24M6.41M8.89M6.99M5.23M5.69M8.08M
Operating items
Research & Development (Quarter)
2.91M3.21M0.98M3.84M4.93M5.33M5.73M6.05M5.66M7.05M4.04M7.37M6.62M5.32M2.04M5.90M6.27M5.32M3.50M3.86M
Selling, General & Administrative (Quarter)
4.30M5.35M6.03M6.63M7.10M6.44M5.65M7.50M7.66M6.82M8.09M7.10M7.64M7.75M7.21M8.53M8.08M6.03M5.48M5.97M
Restructuring Costs (Quarter)
3.06M
Other Operating Expenses (Quarter)
3.53M3.08M6.88M4.21M5.19M5.22M6.25M7.21M7.41M7.30M10.06M7.75M6.65M7.23M10.07M6.76M6.87M4.98M7.93M4.44M
Operating Expenses (Quarter)
10.74M11.64M13.88M14.68M17.23M16.99M17.63M20.75M20.74M21.16M22.19M22.21M20.91M20.29M19.31M21.19M21.21M19.38M16.92M14.27M
Operating Income (Quarter)
-4.42M-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M-11.23M-6.18M
EBIT (Quarter)
-4.42M-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M-11.23M-6.18M
Non-operating items
Non Operating Interest Expenses (Quarter)
0.01M0.29M0.12M0.01M
Interest & Investment Income (Quarter)
0.01M0.05M0.08M0.09M0.48M1.39M1.95M2.30M2.56M2.70M2.82M2.75M2.59M2.50M2.30M2.03M1.87M1.73M1.63M1.44M
Other Non Operating Income (Quarter)
-0.00M-0.24M0.08M0.09M0.48M1.28M1.94M2.30M2.56M2.70M2.82M2.75M2.59M2.50M-7.45M2.03M1.87M1.73M-4.39M1.44M
Net income details
EBT (Quarter)
-4.61M-2.48M-4.83M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M
Profit After Tax (Quarter)
-4.42M-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M
Income from Continuing Operations (Quarter)
-4.61M-2.48M-4.83M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M
Consolidated Net Income (Quarter)
-4.61M-2.48M-4.83M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M
Income towards Parent Company (Quarter)
-4.61M-2.48M-4.83M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M
Net Income towards Common Stockholders (Quarter)
-4.61M-2.48M-4.83M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M
Additional items
EPS (Basic) (Quarter)
-0.05-0.03-0.05-0.29-0.10-0.30-0.28-0.11-0.10-0.11-0.05-0.09-0.09-0.11-0.10-0.10-0.12-0.12-0.09-0.04
EPS (Diluted) (Quarter)
-0.05-0.03-0.05-0.29-0.10-0.30-0.28-0.11-0.10-0.11-0.05-0.09-0.09-0.11-0.10-0.10-0.12-0.12-0.09-0.04
Shares Outstanding (Quarter)
84.71M84.71M90.62M101.31M101.43M101.81M101.70M102.85M103.06M103.45M103.27M104.09M104.64M105.11M104.85M105.95M106.40M106.61M106.43M106.88M
Shares Outstanding (Diluted) (Quarter)
84.71M84.71M90.62M101.31M101.43M101.81M101.70M102.85M103.06M103.45M103.27M104.09M104.64M105.11M104.85M105.95M106.40M106.61M106.43M106.88M
EBITDA (Quarter)
-4.42M-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M-11.23M-6.18M
Interest Expenses (Quarter)
0.20M0.09M-0.04M25.46M1.78M24.49M23.82M1.82M1.82M7.51M15.85M2.28M27.23M26.70M54.87M26.70M2.46M7.22M66.54M2.40M